Cytokine networks in glioma

Neurosurgical Review

Volumn 34, Issue 3, 2011, Pages 253-264

  Iwami, Kenichiro ^a   Natsume, Atsushi ^a   Wakabayashi, Toshihiko ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cancer immunology; Cytokine; Gene therapy; Glioma

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CARMUSTINE; CINTREDEKIN BESUDOTOX; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR ALPHA1; INTERLEUKIN 14; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR GAMMA; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR ALPHA; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; INTERLEUKIN 9; NBI 3001; NITROSOUREA; RECOMBINANT INTERLEUKIN 2; TRABEDERSEN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADOPTIVE IMMUNOTHERAPY; ANTIINFLAMMATORY ACTIVITY; ASTROCYTOMA; BRAIN TUMOR; CANCER GENE THERAPY; CELL ACTIVATION; CELL DIFFERENTIATION; CELL GROWTH; COMA; CYTOTOXIC T LYMPHOCYTE; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; DRUG EFFICACY; EXTRACELLULAR MATRIX; GLIOBLASTOMA; GLIOMA; HEART INFARCTION; HELPER CELL; HUMAN; HUMAN CELL; HYPOTENSION; IMMUNOCOMPETENT CELL; INTESTINE PERFORATION; KIDNEY DYSFUNCTION; MELANOMA; NEUROTOXICITY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEIZURE; TUMOR CELL; TUMOR GROWTH; TUMOR IMMUNOLOGY; TUMOR MICROENVIRONMENT; UNSPECIFIED SIDE EFFECT;

EID: 79960007941     PISSN: 03445607     EISSN: 14372320     Source Type: Journal    
DOI: 10.1007/s10143-011-0320-y     Document Type: Review

References (131)

1. L Aigner U Bogdahn 2008 TGF-beta in neural stem cells and in tumors of the central nervous system Cell Tissue Res 331 225 241 17710437 (Pubitemid 350265484)
2. CF Barker RE Billingham 1977 Immunologically privileged sites Adv Immunol 25 1 54 345773 1:STN:280:DyaE1c7ktFygsg%3D%3D
3. U Boehm T Klamp M Groot JC Howard 1997 Cellular responses to interferon-gamma Annu Rev Immunol 15 749 795 9143706 1:CAS:528: DyaK2sXisVGju7o%3D
4. J Boethius H Blomgren VP Collins T Greitz H Strander 1983 The effect of systemic human interferon-alpha administration to patients with glioblastoma multiforme Acta Neurochir (Wien) 68 239 251 1:STN:280:DyaL3s3nvFantA%3D%3D (Pubitemid 13034552)
5. U Bogdahn P Hau G Stockhammer NK Venkataramana AK Mahapatra A Suri A Balasubramaniam S Nair V Oliushine V Parfenov I Poverennova M Zaaroor P Jachimczak S Ludwig S Schmaus H Heinrichs KH Schlingensiepen 2011 Targeted therapy for high-grade glioma with the TGF-{beta}2 inhibitor trabedersen: results of a randomized and controlled phase IIb study Neuro Oncol 13 132 142 20980335 1:CAS:528:DC%2BC3MXhvFOiur8%3D
6. LC Borish JW Steinke 2003 2. Cytokines and chemokines J Allergy Clin Immunol 111 S460 S475 12592293 1:CAS:528:DC%2BD3sXisleitbc%3D
7. JL Boulay WE Paul 1992 The interleukin-4-related lymphokines and their binding to hematopoietin receptors J Biol Chem 267 20525 20528 1400369 1:CAS:528:DyaK38XmtFSht7o%3D
8. AA Brandes E Scelzi P Zampieri A Rigon A Rotilio P Amista F Berti MV Fiorentino 1997 Phase II trial with BCNU plus alpha-interferon in patients with recurrent high-grade gliomas Am J Clin Oncol 20 364 367 9256890 1:STN:280:DyaK2svgtFSgsQ%3D%3D (Pubitemid 27329568)
9. JC Buckner LD Brown JW Kugler TL Cascino JE Krook JA Mailliard CG Kardinal LK Tschetter JR O'Fallon BW Scheithauer 1995 Phase II evaluation of recombinant interferon alpha and BCNU in recurrent glioma J Neurosurg 82 430 435 7861221 1:STN:280:DyaK2M7msFaisg%3D%3D
10. H Cabrillat JP Galizzi O Djossou N Arai T Yokota K Arai J Banchereau 1987 High affinity binding of human interleukin 4 to cell lines Biochem Biophys Res Commun 149 995 1001 2962580 1:CAS:528:DyaL1cXlsVWrtw%3D%3D (Pubitemid 18024658)
11. G Cai RA Kastelein CA Hunter 1999 IL-10 enhances NK cell proliferation, cytotoxicity and production of IFN-gamma when combined with IL-18 Eur J Immunol 29 2658 2665 10508240 1:CAS:528:DyaK1MXlvFOqtrc%3D (Pubitemid 30098990)
12. MJ Carson JM Doose B Melchior CD Schmid CC Ploix 2006 CNS immune privilege: hiding in plain sight Immunol Rev 213 48 65 16972896 (Pubitemid 44401493)
13. M Chawla-Sarkar DW Leaman EC Borden 2001 Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2: correlation with TRAIL/Apo2L induction in melanoma cell lines Clin Cancer Res 7 1821 1831 11410525 1:CAS:528:DC%2BD3MXltV2hsLY%3D (Pubitemid 32708654)
14. M Chawla-Sarkar DJ Lindner YF Liu BR Williams GC Sen RH Silverman EC Borden 2003 Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis Apoptosis 8 237 249 12766484 1:CAS:528: DC%2BD3sXjsF2nt70%3D (Pubitemid 36749609)
15. EA Chiocca KM Smith B McKinney CA Palmer S Rosenfeld K Lillehei A Hamilton BK DeMasters K Judy D Kirn 2008 A phase I trial of Ad.hIFN-beta gene therapy for glioma Mol Ther 16 618 626 18180770 1:CAS:528:DC%2BD1cXisFOku7Y%3D (Pubitemid 351315003)
16. F Colombo L Barzon E Franchin M Pacenti V Pinna D Danieli M Zanusso G Palu 2005 Combined HSV-TK/IL-2 gene therapy in patients with recurrent glioblastoma multiforme: biological and clinical results Cancer Gene Ther 12 835 848 15891772 1:CAS:528:DC%2BD2MXhtVSjt7rF (Pubitemid 43086285)
17. HF Cserr PM Knopf 1992 Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view Immunol Today 13 507 512 1463583 1:STN:280:DyaK3s%2FpvVyksw%3D%3D
18. W Debinski NI Obiri SK Powers I Pastan RK Puri 1995 Human glioma cells overexpress receptors for interleukin 13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 and pseudomonas exotoxin Clin Cancer Res 1 1253 1258 9815919 1:CAS:528:DyaK28XjvF2htw%3D%3D
19. S Della Bella S Nicola A Riva M Biasin M Clerici ML Villa 2004 Functional repertoire of dendritic cells generated in granulocyte macrophage-colony stimulating factor and interferon-alpha J Leukoc Biol 75 106 116 14525963 1:CAS:528:DC%2BD2cXmsFeluw%3D%3D (Pubitemid 38166785)
20. R Derynck YE Zhang 2003 Smad-dependent and Smad-independent pathways in TGF-beta family signalling Nature 425 577 584 14534577 1:CAS:528: DC%2BD3sXnvV2hs7c%3D (Pubitemid 37280136)
21. RO Dillman M Wiemann RK Oldham G Soori M Bury R Hafer C Church C DePriest 1995 Interferon alpha-2a and external beam radiotherapy in the initial management of patients with glioma: a pilot study of the National Biotherapy Study Group Cancer Biother 10 265 271 8590891 1:CAS:528:DyaK28XltlyqtQ%3D%3D
22. JJ Dubost C Rolhion A Tchirkov S Bertrand J Chassagne A Dosgilbert P Verrelle 2002 Interleukin-6-producing cells in a human glioblastoma cell line are not affected by ionizing radiation J Neurooncol 56 29 34 11949824 (Pubitemid 34256615)
23. M Ehtesham K Samoto P Kabos FL Acosta MA Gutierrez KL Black JS Yu 2002 Treatment of intracranial glioma with in situ interferon-gamma and tumor necrosis factor-alpha gene transfer Cancer Gene Ther 9 925 934 12386831 1:CAS:528:DC%2BD38XnvFWjs7Y%3D (Pubitemid 35278565)
24. M Farkkila J Jaaskelainen M Kallio G Blomstedt R Raininko P Virkkunen A Paetau H Sarelin M Mantyla 1994 Randomised, controlled study of intratumoral recombinant gamma-interferon treatment in newly diagnosed glioblastoma Br J Cancer 70 138 141 8018525 1:STN:280:DyaK2c3ovFamug%3D%3D (Pubitemid 24203641)
25. S Fillatreau D Gray SM Anderton 2008 Not always the bad guys: B cells as regulators of autoimmune pathology Nat Rev Immunol 8 391 397 18437156 1:CAS:528:DC%2BD1cXltFejsbY%3D (Pubitemid 351595221)
26. DF Fiorentino MW Bond TR Mosmann 1989 Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones J Exp Med 170 2081 2095 2531194 1:CAS:528:DyaK3cXhtFKqtL0%3D
27. BM Foxwell G Woerly B Ryffel 1989 Identification of interleukin 4 receptor-associated proteins and expression of both high- and low-affinity binding on human lymphoid cells Eur J Immunol 19 1637 1641 2529125 1:CAS:528:DyaL1MXmtlSgur0%3D (Pubitemid 19243883)
28. JP Galizzi CE Zuber N Harada DM Gorman O Djossou R Kastelein J Banchereau M Howard A Miyajima 1990 Molecular cloning of a cDNA encoding the human interleukin 4 receptor Int Immunol 2 669 675 2278997 1:STN:280: DyaK3M7itVGntQ%3D%3D (Pubitemid 20232466)
29. J Gehrmann Y Matsumoto GW Kreutzberg 1995 Microglia: intrinsic immuneffector cell of the brain Brain Res Brain Res Rev 20 269 287 7550361 1:STN:280:DyaK28%2FjtFOmsA%3D%3D
30. J George NL Banik SK Ray 2009 Combination of hTERT knockdown and IFN-gamma treatment inhibited angiogenesis and tumor progression in glioblastoma Clin Cancer Res 15 7186 7195 19934306 1:CAS:528:DC%2BD1MXhsFSnu7zJ
31. H Groux M Bigler JE de Vries MG Roncarolo 1998 Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells J Immunol 160 3188 3193 9531274 1:CAS:528:DyaK1cXitFWnu78%3D (Pubitemid 28164707)
32. MD Groves VK Puduvalli MR Gilbert VA Levin CA Conrad VH Liu K Hunter C Meyers KR Hess WK Alfred Yung 2009 Two phase II trials of temozolomide with interferon-alpha2b (pegylated and non-pegylated) in patients with recurrent glioblastoma multiforme Br J Cancer 101 615 620 19672263 1:CAS:528: DC%2BD1MXpvFyisbw%3D
33. A Haque NL Banik SK Ray 2007 Emerging role of combination of all-trans retinoic acid and interferon-gamma as chemoimmunotherapy in the management of human glioblastoma Neurochem Res 32 2203 2209 17676389 1:CAS:528: DC%2BD2sXht1Gks77F (Pubitemid 350059864)
34. A Haque A Das LM Hajiaghamohseni A Younger NL Banik SK Ray 2007 Induction of apoptosis and immune response by all-trans retinoic acid plus interferon-gamma in human malignant glioblastoma T98G and U87MG cells Cancer Immunol Immunother 56 615 625 16947022 1:CAS:528:DC%2BD2sXisVaqtb8%3D (Pubitemid 46348732)
35. P Hau P Jachimczak R Schlingensiepen F Schulmeyer T Jauch A Steinbrecher A Brawanski M Proescholdt J Schlaier J Buchroithner J Pichler G Wurm M Mehdorn R Strege G Schuierer V Villarrubia F Fellner O Jansen T Straube V Nohria M Goldbrunner M Kunst S Schmaus G Stauder U Bogdahn KH Schlingensiepen 2007 Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I/II studies Oligonucleotides 17 201 212 17638524 1:CAS:528:DC%2BD2sXnsl2nsro%3D (Pubitemid 47124417)
36. CM Hawrylowicz A O'Garra 2005 Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma Nat Rev Immunol 5 271 283 15775993 1:CAS:528:DC%2BD2MXivVaku7g%3D (Pubitemid 40516153)
37. RL Hayes M Koslow EM Hiesiger KB Hymes HS Hochster EJ Moore DM Pierz DK Chen GN Budzilovich J Ransohoff 1995 Improved long term survival after intracavitary interleukin-2 and lymphokine-activated killer cells for adults with recurrent malignant glioma Cancer 76 840 852 8625188 1:CAS:528: DyaK2MXosVejsLY%3D
38. DS Heo SJ Yoon WS Kim KH Lee JG Seol SG Lee CW Jung EK Cho CW Kim MH Park MW Sung KH Kim YJ Bang NK Kim 1998 Locoregional response and increased natural killer activity after intratumoral injection of HLA-B7/beta2-microglobulin gene in patients with cancer Hum Gene Ther 9 2031 2038 9759930 1:CAS:528: DyaK1cXmtlSmsLk%3D (Pubitemid 28463921)
39. K Hirakawa S Ueda Y Nakagawa K Suzuki S Fukuma M Kita J Imanishi T Kishida 1983 Effect of human leukocyte interferon on malignant brain tumors Cancer 51 1976 1981 6839290 1:STN:280:DyaL3s7otVaiug%3D%3D (Pubitemid 13092443)
40. MD Hjelmeland AB Hjelmeland S Sathornsumetee ED Reese MH Herbstreith NJ Laping HS Friedman DD Bigner XF Wang JN Rich 2004 SB-431542, a small molecule transforming growth factor-beta-receptor antagonist, inhibits human glioma cell line proliferation and motility Mol Cancer Ther 3 737 745 15210860 1:CAS:528:DC%2BD2cXltVajsL0%3D (Pubitemid 39193755)
41. TK Hoffmann G Dworacki T Tsukihiro N Meidenbauer W Gooding JT Johnson TL Whiteside 2002 Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance Clin Cancer Res 8 2553 2562 12171883 (Pubitemid 34856339)
42. FP Holladay T Heitz-Turner WL Bayer GW Wood 1996 Autologous tumor cell vaccination combined with adoptive cellular immunotherapy in patients with grade III/IV astrocytoma J Neurooncol 27 179 189 8699241 1:STN:280: DyaK283jsVOksA%3D%3D (Pubitemid 26052654)
43. K Honda S Sakaguchi C Nakajima A Watanabe H Yanai M Matsumoto T Ohteki T Kaisho A Takaoka S Akira T Seya T Taniguchi 2003 Selective contribution of IFN-alpha/beta signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection Proc Natl Acad Sci USA 100 10872 10877 12960379 1:CAS:528:DC%2BD3sXnslyntLw%3D (Pubitemid 37140120)
44. M Hotfilder H Knupfer G Mohlenkamp P Pennekamp M Knupfers S Van Gool JE Wolff 2000 Interferon-gamma increases IL-6 production in human glioblastoma cell lines Anticancer Res 20 4445 4450 11205286 1:CAS:528:DC%2BD3MXhtVejsLo%3D (Pubitemid 32141801)
45. S Hu CC Chao LC Ehrlich WS Sheng RL Sutton GL Rockswold PK Peterson 1999 Inhibition of microglial cell RANTES production by IL-10 and TGF-beta J Leukoc Biol 65 815 821 10380904 1:CAS:528:DyaK1MXktVCitrw%3D (Pubitemid 29279531)
46. AY Huang P Golumbek M Ahmadzadeh E Jaffee D Pardoll H Levitsky 1994 Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens Science 264 961 965 7513904 1:CAS:528:DyaK2cXjt1SqtbY%3D (Pubitemid 24196166)
47. C Huettner W Paulus W Roggendorf 1995 Messenger RNA expression of the immunosuppressive cytokine IL-10 in human gliomas Am J Pathol 146 317 322 7856743 1:CAS:528:DyaK2MXkslahsbc%3D
48. A Isaacs J Lindenmann 1957 Virus interference. I. The interferon Proc R Soc Lond B Biol Sci 147 258 267 13465720 1:STN:280:DyaG1c%2FgvVekuw%3D%3D
49. SK Jacobs DJ Wilson PL Kornblith EA Grimm 1986 Interleukin-2 or autologous lymphokine-activated killer cell treatment of malignant glioma: phase I trial Cancer Res 46 2101 2104 3512079 1:STN:280:DyaL287jtlejsQ%3D%3D (Pubitemid 16117915)
50. EM Jaffee DM Pardoll 1997 Considerations for the clinical development of cytokine gene-transduced tumor cell vaccines Methods 12 143 153 9184378 1:CAS:528:DyaK2sXjtlSksr4%3D (Pubitemid 27241370)
51. SB Jakowlew 2006 Transforming growth factor-beta in cancer and metastasis Cancer Metastasis Rev 25 435 457 16951986 1:CAS:528:DC%2BD28Xht1yktb3N (Pubitemid 44922360)
52. SA Joosten TH Ottenhoff 2008 Human CD4 and CD8 regulatory T cells in infectious diseases and vaccination Hum Immunol 69 760 770 18835413 1:CAS:528:DC%2BD1cXhsVWls7%2FI
53. R Kim M Emi K Tanabe 2006 Cancer immunosuppression and autoimmune disease: beyond immunosuppressive networks for tumour immunity Immunology 119 254 264 17005005 1:CAS:528:DC%2BD28XhtVOmtb7O (Pubitemid 44401644)
54. M Kioi S Seetharam RK Puri 2008 Targeting IL-13Ralpha2-positive cancer with a novel recombinant immunotoxin composed of a single-chain antibody and mutated Pseudomonas exotoxin Mol Cancer Ther 7 1579 1587 18566228 1:CAS:528:DC%2BD1cXnsVSktb8%3D
55. C Kjellman SP Olofsson O Hansson T Von Schantz M Lindvall I Nilsson LG Salford HO Sjogren B Widegren 2000 Expression of TGF-beta isoforms, TGF-beta receptors, and SMAD molecules at different stages of human glioma Int J Cancer 89 251 258 10861501 1:STN:280:DC%2BD3czitFCisA%3D%3D (Pubitemid 30430741)
56. MJ Knight CD Riffkin AM Muscat DM Ashley CJ Hawkins 2001 Analysis of FasL and TRAIL induced apoptosis pathways in glioma cells Oncogene 20 5789 5798 11593384 1:CAS:528:DC%2BD3MXntlSgtro%3D (Pubitemid 32937948)
57. MM Knupfer H Poppenborg S Van Gool M Domula JE Wolff 1997 Interferon-gamma inhibits proliferation and adhesion of T98G human malignant glioma cells in vitro Klin Pädiatr 209 271 274 9293461 1:STN:280: DyaK2svjvFSjuw%3D%3D (Pubitemid 27328980)
58. MM Knupfer H Knupfer S Van Gool M Domula JE Wolff 2000 Interferon gamma inhibits proliferation and hyaluronic acid adhesion of human malignant glioma cells in vitro Cytokine 12 409 412 10805225 1:CAS:528:DC%2BD3cXit1Cnurk%3D (Pubitemid 30449835)
59. MM Knupfer H Knupfer V Jendrossek S Van Gool JE Wolff E Keller 2001 Interferon-gamma inhibits growth and migration of A172 human glioblastoma cells Anticancer Res 21 3989 3994 11911281 1:CAS:528:DC%2BD38Xis1art7k%3D (Pubitemid 34229274)
60. CA Kruse L Cepeda B Owens SD Johnson J Stears KO Lillehei 1997 Treatment of recurrent glioma with intracavitary alloreactive cytotoxic T lymphocytes and interleukin-2 Cancer Immunol Immunother 45 77 87 9390198 1:CAS:528: DyaK2sXotVOju7k%3D (Pubitemid 27497682)
61. BW Krushelnycky MA Farr-Jones B Mielke JD McKean BK Weir KC Petruk 1991 Development of a large-animal human brain tumor xenograft model in immunosuppressed cats Cancer Res 51 2430 2437 2015604 1:STN:280: DyaK3M7pvFSqtg%3D%3D
62. S Kunwar SM Chang MD Prados MS Berger JH Sampson D Croteau JW Sherman AY Grahn VS Shu JL Dul SR Husain BH Joshi C Pedain RK Puri 2006 Safety of intraparenchymal convection-enhanced delivery of cintredekin besudotox in early-phase studies Neurosurg Focus 20 E15 16709020
63. A Le Bon N Etchart C Rossmann M Ashton S Hou D Gewert P Borrow DF Tough 2003 Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon Nat Immunol 4 1009 1015 14502286 (Pubitemid 37265922)
64. JJ Letterio AB Roberts 1998 Regulation of immune responses by TGF-beta Annu Rev Immunol 16 137 161 9597127 1:CAS:528:DyaK1cXislyhsrk%3D
65. S Liu Y Yu M Zhang W Wang X Cao 2001 The involvement of TNF-alpha-related apoptosis-inducing ligand in the enhanced cytotoxicity of IFN-beta-stimulated human dendritic cells to tumor cells J Immunol 166 5407 5415 11313377 1:CAS:528:DC%2BD3MXjtFyrtLo%3D (Pubitemid 32374160)
66. B Ljungberg K Grankvist T Rasmuson 1997 Serum interleukin-6 in relation to acute-phase reactants and survival in patients with renal cell carcinoma Eur J Cancer 33 1794 1798 9470835 1:STN:280:DyaK1c7jtFKisw%3D%3D (Pubitemid 28129206)
67. DN Louis H Ohgaki OD Wiestler WK Cavenee PC Burger A Jouvet BW Scheithauer P Kleihues 2007 The 2007 WHO classification of tumours of the central nervous system Acta Neuropathol 114 97 109 17618441 (Pubitemid 47103521)
68. J Massague 1998 TGF-beta signal transduction Annu Rev Biochem 67 753 791 9759503 1:CAS:528:DyaK1cXlsFOmsbY%3D
69. P Matarrese L Di Biase L Santodonato E Straface M Mecchia B Ascione G Parmiani F Belardelli M Ferrantini W Malorni 2002 Type I interferon gene transfer sensitizes melanoma cells to apoptosis via a target activity on mitochondrial function Am J Pathol 160 1507 1520 11943735 1:CAS:528: DC%2BD38XjsFGjtLw%3D (Pubitemid 34411654)
70. PL McGeer S Itagaki EG McGeer 1988 Expression of the histocompatibility glycoprotein HLA-DR in neurological disease Acta Neuropathol 76 550 557 2974227 1:STN:280:DyaL1M%2FnsVWnsw%3D%3D
71. PB Medawar 1948 Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye Br J Exp Pathol 29 58 69 18865105 1:STN:280:DyaH1c%2FgvVymsA%3D%3D
72. PJ Miettinen R Ebner AR Lopez R Derynck 1994 TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors J Cell Biol 127 2021 2036 7806579 1:CAS:528:DyaK2MXitlWgsrw%3D
73. M Montoya G Schiavoni F Mattei I Gresser F Belardelli P Borrow DF Tough 2002 Type I interferons produced by dendritic cells promote their phenotypic and functional activation Blood 99 3263 3271 11964292 1:CAS:528: DC%2BD38XjtlOmsLo%3D (Pubitemid 34525306)
74. KW Moore P Vieira DF Fiorentino ML Trounstine TA Khan TR Mosmann 1990 Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI Science 248 1230 1234 2161559 1:CAS:528:DyaK3cXlvVGlurc%3D
75. KW Moore MR de Waal RL Coffman A O'Garra 2001 Interleukin-10 and the interleukin-10 receptor Annu Rev Immunol 19 683 765 11244051 1:CAS:528:DC%2BD3MXivFKgu70%3D (Pubitemid 32368050)
76. R Moqbel S Ying J Barkans TM Newman P Kimmitt M Wakelin L Taborda-Barata Q Meng CJ Corrigan SR Durham AB Kay 1995 Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product J Immunol 155 4939 4947 7594499 1:CAS:528:DyaK2MXptlejsLg%3D
77. TR Mosmann H Cherwinski MW Bond MA Giedlin RL Coffman 1986 Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins J Immunol 136 2348 2357 2419430 1:CAS:528:DyaL28XhvVClsbk%3D (Pubitemid 16136806)
78. M Mut JH Sherman ME Shaffrey D Schiff 2008 Cintredekin besudotox in treatment of malignant glioma Expert Opin Biol Ther 8 805 812 18476792 1:CAS:528:DC%2BD1cXlslyksbw%3D (Pubitemid 351860210)
79. M Nagai T Arai 1984 Clinical effect of interferon in malignant brain tumours Neurosurg Rev 7 55 64 6379511 1:STN:280:DyaL2c3ntFagsQ%3D%3D
80. Y Nakagawa K Hirakawa S Ueda K Suzuki S Fukuma T Kishida J Imanishi T Amagai 1983 Local administration of interferon for malignant brain tumors Cancer Treat Rep 67 833 835 6688376 1:STN:280:DyaL3s3osV2kuw%3D%3D (Pubitemid 13007291)
81. N Nakahara IF Pollack WJ Storkus T Wakabayashi J Yoshida H Okada 2003 Effective induction of antiglioma cytotoxic T cells by coadministration of interferon-beta gene vector and dendritic cells Cancer Gene Ther 10 549 558 12833135 1:CAS:528:DC%2BD3sXkvFegs74%3D (Pubitemid 36842012)
82. A Natsume M Mizuno Y Ryuke J Yoshida 1999 Antitumor effect and cellular immunity activation by murine interferon-beta gene transfer against intracerebral glioma in mouse Gene Ther 6 1626 1633 10490773 1:CAS:528:DyaK1MXmtFClsLg%3D (Pubitemid 29465522)
83. A Natsume K Tsujimura M Mizuno T Takahashi J Yoshida 2000 IFN-beta gene therapy induces systemic antitumor immunity against malignant glioma J Neurooncol 47 117 124 10982152 1:STN:280:DC%2BD3M7htFOntw%3D%3D (Pubitemid 30665322)
84. A Natsume D Ishii T Wakabayashi T Tsuno H Hatano M Mizuno J Yoshida 2005 IFN-beta down-regulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide Cancer Res 65 7573 7579 16140920 1:CAS:528:DC%2BD2MXpslaitL0%3D (Pubitemid 41297227)
85. A Natsume T Wakabayashi D Ishii H Maruta M Fujii S Shimato M Ito J Yoshida 2008 A combination of IFN-beta and temozolomide in human glioma xenograft models: implication of p53-mediated MGMT downregulation Cancer Chemother Pharmacol 61 653 659 17564708 1:CAS:528:DC%2BD1cXjsFWksg%3D%3D
86. U Naumann P Maass AK Gleske S Aulwurm M Weller G Eisele 2008 Glioma gene therapy with soluble transforming growth factor-beta receptors II and III Int J Oncol 33 759 765 18813789 1:CAS:528:DC%2BD1cXht1KhtbbK
87. A O'Garra P Vieira 2007 T(H)1 cells control themselves by producing interleukin-10 Nat Rev Immunol 7 425 428 17525751 (Pubitemid 46834852)
88. A O'Garra FJ Barrat AG Castro A Vicari C Hawrylowicz 2008 Strategies for use of IL-10 or its antagonists in human disease Immunol Rev 223 114 131 18613832 (Pubitemid 351986180)
89. H Okada N Kuwashima 2002 Gene therapy and biologic therapy with interleukin-4 Curr Gene Ther 2 437 450 12477255 1:CAS:528:DC%2BD38XptlGrs78%3D
90. H Okada FS Lieberman HD Edington TF Witham MJ Wargo Q Cai EH Elder TL Whiteside SC Schold Jr IF Pollack 2003 Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of recurrent glioblastoma: preliminary observations in a patient with a favorable response to therapy J Neurooncol 64 13 20 12952282 (Pubitemid 36992456)
91. LS Park D Friend HM Sassenfeld DL Urdal 1987 Characterization of the human B cell stimulatory factor 1 receptor J Exp Med 166 476 488 3496417 1:CAS:528:DyaL2sXlsFamsrY%3D (Pubitemid 17134026)
92. G Parmiani C Castelli L Pilla M Santinami MP Colombo L Rivoltini 2007 Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients Ann Oncol 18 226 232 17116643 1:STN:280:DC%2BD2s%2Fotlekug%3D%3D (Pubitemid 46323086)
93. IF Parney LJ Chang MA Farr-Jones C Hao M Smylie KC Petruk 2006 Technical hurdles in a pilot clinical trial of combined B7-2 and GM-CSF immunogene therapy for glioblastomas and melanomas J Neurooncol 78 71 80 16718522 1:CAS:528:DC%2BD28XotFeit7s%3D (Pubitemid 43786663)
94. MS Pepper 1997 Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity Cytokine Growth Factor Rev 8 21 43 9174661 1:CAS:528:DyaK2sXktFShsbo%3D (Pubitemid 27214687)
95. LM Phillips LA Lampson 1999 Site-specific control of T cell traffic in the brain: T cell entry to brainstem vs. hippocampus after local injection of IFN-gamma J Neuroimmunol 96 218 227 10337920 1:CAS:528:DyaK1MXis1aqtLo%3D (Pubitemid 29234496)
96. M Plaut JH Pierce CJ Watson J Hanley-Hyde RP Nordan WE Paul 1989 Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores Nature 339 64 67 2469965 1:CAS:528:DyaL1MXktVGls7w%3D (Pubitemid 19115894)
97. SV Rajkumar JC Buckner PJ Schomberg TL Cascino PA Burch RP Dinapoli 1998 Phase I evaluation of radiation combined with recombinant interferon alpha-2a and BCNU for patients with high-grade glioma Int J Radiat Oncol Biol Phys 40 297 302 9457812 1:CAS:528:DyaK1cXosVajsQ%3D%3D (Pubitemid 28114371)
98. L Ronnov-Jessen OW Petersen 1993 Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia Lab Invest 68 696 707 8515656 1:STN:280:DyaK3s3psFSrsQ%3D%3D (Pubitemid 23202798)
99. E Roussel MC Gingras EA Grimm JM Bruner RP Moser 1996 Predominance of a type 2 intratumoural immune response in fresh tumour-infiltrating lymphocytes from human gliomas Clin Exp Immunol 105 344 352 8706344 1:CAS:528: DyaK28XltV2qsbY%3D (Pubitemid 26246956)
100. AW Rowbottom MA Lepper RJ Garland CV Cox EG Corley 1999 Interleukin-10-induced CD8 cell proliferation Immunology 98 80 89 10469237 1:CAS:528:DyaK1MXmt1Sktrg%3D (Pubitemid 29425912)
101. AD Santin PL Hermonat A Ravaggi S Bellone S Pecorelli JJ Roman GP Parham MJ Cannon 2000 Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes J Virol 74 4729 4737 10775611 1:CAS:528:DC%2BD3cXivFynsrw%3D (Pubitemid 30237900)
102. SM Santini C Lapenta M Logozzi S Parlato M Spada T Di Pucchio F Belardelli 2000 Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice J Exp Med 191 1777 1788 10811870 1:CAS:528:DC%2BD3cXjtlKgu7o%3D (Pubitemid 30331574)
103. PM Schiltz GG Gomez SB Read NV Kulprathipanja CA Kruse 2002 Effects of IFN-gamma and interleukin-1beta on major histocompatibility complex antigen and intercellular adhesion molecule-1 expression by 9L gliosarcoma: relevance to its cytolysis by alloreactive cytotoxic T lymphocytes J Interferon Cytokine Res 22 1209 1216 12581494 1:CAS:528:DC%2BD3sXhtlChs70%3D (Pubitemid 36432858)
104. KH Schlingensiepen R Schlingensiepen A Steinbrecher P Hau U Bogdahn B Fischer-Blass P Jachimczak 2006 Targeted tumor therapy with the TGF-beta 2 antisense compound AP 12009 Cytokine Growth Factor Rev 17 129 139 16377233 1:CAS:528:DC%2BD28Xos1Crsg%3D%3D (Pubitemid 43117522)
105. T Schneider A Becker K Ringe A Reinhold R Firsching BA Sabel 2008 Brain tumor therapy by combined vaccination and antisense oligonucleotide delivery with nanoparticles J Neuroimmunol 195 21 27 18304655 1:CAS:528: DC%2BD1cXkvVOrsb0%3D
106. BM Segal DD Glass EM Shevach 2002 Cutting Edge: IL-10-producing CD4+ T cells mediate tumor rejection J Immunol 168 1 4 11751938 1:CAS:528: DC%2BD38Xht1Cqtw%3D%3D (Pubitemid 34014094)
107. YA Sidky EC Borden 1987 Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses Cancer Res 47 5155 5161 2441862 1:CAS:528:DyaL2sXmtFGqsbk%3D (Pubitemid 17146488)
108. AE Sloan R Dansey L Zamorano G Barger C Hamm F Diaz R Baynes G Wood 2000 Adoptive immunotherapy in patients with recurrent malignant glioma: preliminary results of using autologous whole-tumor vaccine plus granulocyte-macrophage colony-stimulating factor and adoptive transfer of anti-CD3-activated lymphocytes Neurosurg Focus 9 e9 16817692 1:STN:280:DC%2BD28vgtVahug%3D%3D
109. R Stupp WP Mason MJ van den Bent M Weller B Fisher MJ Taphoorn K Belanger AA Brandes C Marosi U Bogdahn J Curschmann RC Janzer SK Ludwin T Gorlia A Allgeier D Lacombe JG Cairncross E Eisenhauer RO Mirimanoff 2005 Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 987 996 15758009 1:CAS:528:DC%2BD2MXit1Wksbk%3D (Pubitemid 40349501)
110. M Tada AC Diserens I Desbaillets N de Tribolet 1994 Analysis of cytokine receptor messenger RNA expression in human glioblastoma cells and normal astrocytes by reverse-transcription polymerase chain reaction J Neurosurg 80 1063 1073 7514661 1:CAS:528:DyaK2cXkvVSksLk%3D (Pubitemid 24154184)
111. L Thyrell S Erickson B Zhivotovsky K Pokrovskaja O Sangfelt J Castro S Einhorn D Grander 2002 Mechanisms of interferon-alpha induced apoptosis in malignant cells Oncogene 21 1251 1262 11850845 1:CAS:528:DC%2BD38XitFSjt70%3D (Pubitemid 34185242)
112. NN Tran Thang M Derouazi G Philippin S Arcidiaco W Di Berardino-Besson F Masson S Hoepner C Riccadonna K Burkhardt A Guha PY Dietrich PR Walker 2010 Immune infiltration of spontaneous mouse astrocytomas is dominated by immunosuppressive cells from early stages of tumor development Cancer Res 70 4829 4839 20501837
113. TT Tran M Uhl JY Ma L Janssen V Sriram S Aulwurm I Kerr A Lam HK Webb AM Kapoun DE Kizer G McEnroe B Hart J Axon A Murphy S Chakravarty S Dugar AA Protter LS Higgins W Wick M Weller DH Wong 2007 Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model Neuro Oncol 9 259 270 17522330 1:CAS:528:DC%2BD2sXpt1agsL8%3D (Pubitemid 47169658)
114. M Uhl S Aulwurm J Wischhusen M Weiler JY Ma R Almirez R Mangadu YW Liu M Platten U Herrlinger A Murphy DH Wong W Wick LS Higgins M Weller 2004 SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo Cancer Res 64 7954 7961 15520202 1:CAS:528: DC%2BD2cXptFels78%3D (Pubitemid 39446929)
115. L Vallieres 2009 Trabedersen, a TGFbeta2-specific antisense oligonucleotide for the treatment of malignant gliomas and other tumors overexpressing TGFbeta2 IDrugs 12 445 453 19579166 1:CAS:528: DC%2BC3cXpt1yrsbc%3D
116. J Vaquero R Martinez 1992 Intratumoral immunotherapy with interferon-alpha and interleukin-2 in glioblastoma Neuroreport 3 981 983 1336409 1:STN:280:DyaK3s7ivFOksA%3D%3D
117. JR Velazquez P Lacy S Mahmudi-Azer B Bablitz CD Milne JA Denburg R Moqbel 2000 Interleukin-4 and RANTES expression in maturing eosinophils derived from human cord blood CD34+ progenitors Immunology 101 419 425 11106947 1:CAS:528:DC%2BD3cXoslWmsr4%3D
118. T Wakabayashi N Hatano Y Kajita T Yoshida M Mizuno K Taniguchi T Ohno T Nagasaka J Yoshida 2000 Initial and maintenance combination treatment with interferon-beta, MCNU (Ranimustine), and radiotherapy for patients with previously untreated malignant glioma J Neurooncol 49 57 62 11131987 1:STN:280:DC%2BD3M7ns1WltA%3D%3D
119. T Wakabayashi A Natsume Y Hashizume M Fujii M Mizuno J Yoshida 2008 A phase I clinical trial of interferon-beta gene therapy for high-grade glioma: novel findings from gene expression profiling and autopsy J Gene Med 10 329 339 18220319 1:CAS:528:DC%2BD1cXlvFehurg%3D (Pubitemid 351517089)
120. JJ Watters JM Schartner B Badie 2005 Microglia function in brain tumors J Neurosci Res 81 447 455 15959903 1:CAS:528:DC%2BD2MXnsVeltb8%3D (Pubitemid 41359299)
121. F Weber A Asher R Bucholz M Berger M Prados S Chang J Bruce W Hall NG Rainov M Westphal RE Warnick RW Rand F Floeth F Rommel H Pan VN Hingorani RK Puri 2003 Safety, tolerability, and tumor response of IL4-Pseudomonas exotoxin (NBI-3001) in patients with recurrent malignant glioma J Neurooncol 64 125 137 12952293 (Pubitemid 36992467)
122. LM Williams G Ricchetti U Sarma T Smallie BM Foxwell 2004 Interleukin-10 suppression of myeloid cell activation-a continuing puzzle Immunology 113 281 292 15500614 1:CAS:528:DC%2BD2cXpvV2jtbY%3D (Pubitemid 39472144)
123. S Wintterle B Schreiner M Mitsdoerffer D Schneider L Chen R Meyermann M Weller H Wiendl 2003 Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis Cancer Res 63 7462 7467 14612546 1:CAS:528:DC%2BD3sXovVGltb0%3D (Pubitemid 37413489)
124. JE Wolff S Wagner C Reinert A Gnekow RD Kortmann J Kuhl SW Van Gool 2006 Maintenance treatment with interferon-gamma and low-dose cyclophosphamide for pediatric high-grade glioma J Neurooncol 79 315 321 16645718 1:CAS:528:DC%2BD28Xht1Shur3I (Pubitemid 44363736)
125. M Wrann S Bodmer R de Martin C Siepl R Hofer-Warbinek K Frei E Hofer A Fontana 1987 T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-beta EMBO J 6 1633 1636 3497030 1:CAS:528:DyaL2sXksFOitb0%3D
126. A Wu J Wei LY Kong Y Wang W Priebe W Qiao R Sawaya AB Heimberger 2010 Glioma cancer stem cells induce immunosuppressive macrophages/microglia Neuro Oncol 12 1113 1125 20667896 1:CAS:528:DC%2BC3cXhtlClu7fO
127. TA Wynn 2003 IL-13 effector functions Annu Rev Immunol 21 425 456 12615888 1:CAS:528:DC%2BD3sXjtF2isrY%3D (Pubitemid 37174537)
128. J Yoshida Y Kajita T Wakabayashi K Sugita 1994 Long-term follow-up results of 175 patients with malignant glioma: importance of radical tumour resection and postoperative adjuvant therapy with interferon, ACNU and radiation Acta Neurochir (Wien) 127 55 59 1:STN:280:DyaK2M%2FivVKmtg%3D%3D (Pubitemid 24093475)
129. J Yoshida M Mizuno M Fujii Y Kajita N Nakahara M Hatano R Saito M Nobayashi T Wakabayashi 2004 Human gene therapy for malignant gliomas (glioblastoma multiforme and anaplastic astrocytoma) by in vivo transduction with human interferon beta gene using cationic liposomes Hum Gene Ther 15 77 86 14965379 1:CAS:528:DC%2BD2cXjtFGgsg%3D%3D (Pubitemid 38147190)
130. T Yoshimoto WE Paul 1994 CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3 J Exp Med 179 1285 1295 7908323 1:CAS:528:DyaK2cXhs1Wgt74%3D
131. JP Zou LA Morford C Chougnet AR Dix AG Brooks N Torres JD Shuman JE Coligan WH Brooks TL Roszman GM Shearer 1999 Human glioma-induced